Takeda Pharmaceutical Profit Margin

Takeda Pharmaceutical (TAK) currently reports a profit margin of 3.91% as of June 2026. That compares with 3.06% in the prior-year period — up 27.9% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Takeda Pharmaceutical's profit margin history and peer comparisons.

Takeda Pharmaceutical's profit margin increased from 3.06% to 3.91% — a 27.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Takeda Pharmaceutical's profit margin of 3.91% is lower than the Healthcare sector average of 21.34%. That is roughly 81.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Takeda Pharmaceutical's current 3.91% should be judged against Healthcare norms (sector average: 21.34%) and against TAK's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 3.91%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Takeda Pharmaceutical, and consider following TAK for alerts when major investors trade the stock.